Barclays' upgrade of PTC Therapeutics to Overweight has spotlighted the biotech firm's valuation, with shares showing strong momentum but questions lingering over its path to profitability and reliance on a narrow drug portfolio.
Sanofi announces promising late-stage results for its immunology candidate amlitelimab and expands into genetic therapies via an investment in Sensorion, signaling a strategic push into high-value therapeutic areas.
South Plains Financial (NASDAQ: SPFI) announces an increased quarterly dividend to $0.17 per share, reflecting strong earnings growth and a conservative payout strategy. While the yield remains modest, analysts highlight the company's potential for sustained dividend expansion.
As the Bank of Canada signals a hold on interest rates, a backdrop of market stability is emerging. This analysis delves into three Canadian penny stocks—Britannia Life Sciences, ROK Resources, and Vision Lithium—that present distinct risk-reward profiles for investors eyeing the junior markets in early 2026.
Facing ongoing labor disputes, Starbucks unveils a massive investment in new espresso machines, AI-assisted POS systems, and a store rating program aimed at streamlining operations and improving the partner experience.
A historic rally in gold and silver reversed violently on Friday, with gold futures plummeting over 10% in their sharpest decline since the 1980s and silver recording its largest single-day drop ever, amid a broader market sell-off.
Crude oil and gasoline prices advanced on Friday, supported by persistent geopolitical risks in the Middle East and ongoing supply constraints, though gains were tempered by a stronger dollar and diplomatic signals.
CEO Brian Niccol says employees' questions about share prices reflect pride and care, as the coffee giant navigates workplace reforms and ongoing labor disputes.
Despite significant operational downtime from recent hurricanes, Cavco Industries reports a 12.3% year-over-year revenue increase to $507.5 million for Q2 FY2025, driven by a 15.7% jump in homes shipped. The company remains optimistic on market recovery and announces an additional $100 million share repurchase authorization.
Gold and silver prices retreated sharply from record highs as President Trump's nomination of Kevin Warsh to lead the Federal Reserve eased concerns over central bank independence, triggering a broad profit-taking sell-off.
Barrick Mining Corporation's stock fell nearly 10% Friday, mirroring a sharp drop in gold prices after President Trump's nomination of a mainstream candidate to lead the Federal Reserve calmed market anxieties about runaway inflation.
A growing financial strategy known as 'soft switching'—opening new bank accounts without closing old ones—is gaining traction. Experts say it can unlock higher yields, better features, and greater flexibility, but requires careful management to avoid pitfalls.
Bitcoin's sharp decline this week mirrors a wider market rout, with analysts pointing to a confluence of geopolitical tensions, policy fears, and tech sector volatility as key drivers. The sell-off raises fresh questions about near-term support levels for the flagship cryptocurrency.
Independent Bank Corporation (NASDAQ: IBCP) announces a dividend increase to $0.28 per share, continuing its decade-long track record of shareholder returns. Analysts highlight the payout's sustainability amid solid earnings growth projections.
Shares of the staffing leader surged after its Q4 earnings hinted at a potential end to a multi-year slump, with management pointing to positive sequential growth for the first time since 2021.
With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
Despite a major new Bitcoin purchase, MicroStrategy's stock has plunged to its lowest level since September 2024, as market turbulence and mixed analyst sentiment pressure the crypto-focused software firm ahead of its earnings report.
While retirement planning often focuses on savings, a critical financial metric—net worth—reveals a more precarious reality for many households. We examine the causes and consequences of negative net worth, offering actionable steps to build a stronger financial foundation.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
